\begin{table}[htbp]\centering
\def\sym#1{\ifmmode^{#1}\else\(^{#1}\)\fi}
\caption{Summary statistics for selected variables}
\begin{tabular}{l*{1}{cccc}}
\hline\hline
                    &        Mean&     Minimum&     Maximum&Observations\\
\hline
Uses biomarker      &      0.4092&           0&           1&     131,971\\
Generous PPM        &      0.0643&           0&           1&     131,971\\
Restrictive PPM     &      0.0581&           0&           1&     131,971\\
Biomarker role: disease&      0.0842&           0&           1&     131,971\\
Biomarker role: toxic effect&      0.0496&           0&           1&     131,971\\
Biomarker role: therapeutic effect&      0.3371&           0&           1&     131,971\\
Biomarker role: not determined&      0.0023&           0&           1&     131,971\\
Biomarker type: anthropomorphic&      0.0350&           0&           1&     131,971\\
Biomarker type: biochemical&      0.1248&           0&           1&     131,971\\
Biomarker type: cellular&      0.0308&           0&           1&     131,971\\
Biomarker type: genomic&      0.2321&           0&           1&     131,971\\
Biomarker type: physiological&      0.0849&           0&           1&     131,971\\
Biomarker type: proteomic&      0.2426&           0&           1&     131,971\\
Biomarker type: structural (imaging)&      0.0177&           0&           1&     131,971\\
Biomarker role (detailed): diagnosis&      0.2948&           0&           1&     117,180\\
Biomarker role (detailed): differential diagnosis&      0.1829&           0&           1&     117,180\\
Biomarker role (detailed): predicting drug resistance&      0.0624&           0&           1&     117,180\\
Biomarker role (detailed): predicting treatment efficacy&      0.2568&           0&           1&     117,180\\
Biomarker role (detailed): predicting treatment toxicity&      0.0474&           0&           1&     117,180\\
Biomarker role (detailed): screening&      0.0523&           0&           1&     117,180\\
Biomarker role (detailed): selection for therapy&      0.0938&           0&           1&     117,180\\
Phase 1 Clinical    &      0.3305&           0&           1&     131,971\\
Phase 2 Clinical    &      0.4367&           0&           1&     131,971\\
Phase 3 Clinical    &      0.2328&           0&           1&     131,971\\
Received NIH funding&      0.0282&           0&           1&     131,971\\
Trial site in US    &      0.4368&           0&           1&     113,410\\
Drug indication for neoplasm&      0.3340&           0&           1&     131,971\\
\hline
N                   &     131,971&            &            &            \\
\hline\hline
\end{tabular}
\end{table}
